S100A4 promotes liver fibrosis via activation of hepatic stellate cells

Journal of Hepatology

Volumn 62, Issue 1, 2016, Pages 156-164

  Chen, Lin ^a,b,c   Li, Jie ^a,b,c   Zhang, Jinhua ^a,b   Dai, Chengliang ^a,b,c   Liu, Xiaoman ^a,b   Wang, Jun ^d   Gao, Zhitao ^e   Guo, Hongyan ^f   Wang, Rui ^f   Lu, Shichun ^f   Wang, Fusheng ^g   Zhang, Henghui ^h   Chen, Hongsong ^h   Fan, Xiaolong ⁱ   Wang, Shengdian ^a   Qin, Zhihai ^a,b  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e XINXIANG MEDICAL UNIVERSITY   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

^g BEIJING 302 HOSPITAL   (China)

^h PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

ⁱ BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Activation; Hepatic stellate cells; Liver fibrosis; S100A4

Indexed keywords

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER; ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; CARBON TETRACHLORIDE; DNA; PROTEIN S 100; S100A4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BILE DUCT LIGATION; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROGENESIS; HEPATITIS; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER; LIVER CIRRHOSIS; LIVER FIBROSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; ONCOGENE C MYB; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RNA INTERFERENCE; STELLATE CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; S100 PROTEINS;

EID: 84918823093     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.07.035     Document Type: Article

References (34)

1. R. Bataller, and D.A. Brenner Liver fibrosis J Clin Invest 115 2005 209 218
2. T.A. Wynn, and T.R. Ramalingam Mechanisms of fibrosis: therapeutic translation for fibrotic disease Nat Med 18 2012 1028 1040
3. M. Cohen-Naftaly, and S.L. Friedman Current status of novel anti-fibrotic therapies in patients with chronic liver disease Ther Adv Gastroenterol 4 2011 391 417
4. A.M. Gressner, and R. Weiskirchen Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets J Cell Mol Med 10 2006 76 99
5. I. Mederacke, C.C. Hsu, J.S. Troeger, P. Huebener, X. Mu, and D.H. Dapito Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology Nat Commun 4 2013 2823
6. K. Wake "Sternzellen" in the liver: perisinusoidal cells with special reference to storage of vitamin A Am J Anat 132 1971 429 462
7. S.L. Friedman Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver Physiol Rev 88 2008 125 172
8. N.C. Henderson, and J.P. Iredale Liver fibrosis: cellular mechanisms of progression and resolution Clin Sci (Lond) 112 2007 265 280
9. T. Kisseleva, M. Cong, Y. Paik, D. Scholten, C. Jiang, and C. Benner Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis Proc Natl Acad Sci U S A 109 2012 9448 9453
10. K. Boye, and G.M. Maelandsmo S100-A4 and metastasis: a small actor playing many roles Am J Pathol 176 2010 528 535
11. L. Mazzucchelli Protein S100-A4: too long overlooked by pathologists? Am J Pathol 160 2002 7 13
12. C.H. Osterreicher, M. Penz-Osterreicher, S.I. Grivennikov, M. Guma, E.K. Koltsova, and C. Datz Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver Proc Natl Acad Sci U S A 108 2011 308 313
13. F. Strutz, H. Okada, C.W. Lo, T. Danoff, R.L. Carone, and J.E. Tomaszewski Identification and characterization of a fibroblast marker: FSP1 J Cell Biol 130 1995 393 405
14. J. Zhang, L. Chen, M. Xiao, C. Wang, and Z. Qin FSP1+ fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation Am J Pathol 178 2011 382 390
15. E.J. Kim, and D.M. Helfman Characterization of the metastasis-Associated protein, S100-A4. Roles of calcium binding and dimerization in cellular localization and interaction with myosin J Biol Chem 278 2003 30063 30073
16. D. Kiryushko, V. Novitskaya, V. Soroka, J. Klingelhofer, E. Lukanidin, and V. Berezin Molecular mechanisms of Ca(2+) signaling in neurons induced by the S100-A4 protein Mol Cell Biol 26 2006 3625 3638
17. M. Iwano, A. Fischer, H. Okada, D. Plieth, C. Xue, and T.M. Danoff Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts Mol Ther 3 2001 149 159
18. W.E. Lawson, V.V. Polosukhin, O. Zoia, G.T. Stathopoulos, W. Han, and D. Plieth Characterization of fibroblast-specific protein 1 in pulmonary fibrosis Am J Respir Crit Care Med 171 2005 899 907
19. J. Wang, W. Zhao, L. Cheng, M. Guo, D. Li, and X. Li CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice J Immunol 185 2010 7654 7662
20. N. Kawada, T. Kuroki, K. Kobayashi, M. Inoue, K. Nakatani, and K. Kaneda Expression of heat-shock protein 47 in mouse liver Cell Tissue Res 284 1996 341 346
21. J.S. Duffield, S.J. Forbes, C.M. Constandinou, S. Clay, M. Partolina, and S. Vuthoori Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair J Clin Invest 115 2005 56 65
22. P. Ramachandran, A. Pellicoro, M.A. Vernon, L. Boulter, R.L. Aucott, and A. Ali Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis Proc Natl Acad Sci U S A 109 2012 E3186 E3195
23. M. Iwano, D. Plieth, T.M. Danoff, C. Xue, H. Okada, and E.G. Neilson Evidence that fibroblasts derive from epithelium during tissue fibrosis J Clin Invest 110 2002 341 350
24. C. Xue, D. Plieth, C. Venkov, C. Xu, and E.G. Neilson The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis Cancer Res 63 2003 3386 3394
25. W. Chang, M. Yang, L. Song, K. Shen, H. Wang, and X. Gao Isolation and culture of hepatic stellate cells from mouse liver Acta Biochim Biophys Sin 46 2014 291 298
26. K.S. Lee, H.B. Cottam, K. Houglum, D.B. Wasson, D. Carson, and M. Chojkier Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitory activity Am J Physiol 273 1997 G1094 G1100
27. T. Kitada, S. Seki, K. Nakatani, N. Kawada, T. Kuroki, and T. Monna Hepatic expression of c-Myb in chronic human liver disease Hepatology 26 1997 1506 1512
28. S. Ragozin, A. Niemeier, A. Laatsch, B. Loeffler, M. Merkel, and U. Beisiegel Knockdown of hepatic ABCA1 by RNA interference decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice Arterioscler Thromb Vasc Biol 25 2005 1433 1438
29. M. Tomcik, L. Andres Cerezo, S. Skacelova, M. Komarc, R. Becvar, and M. Grigorian A3.16 Serum S100-A4 correlates with skin fibrosis, lung involvement and disease activity in systemic sclerosis Ann Rheum Dis 73 2014 A48
30. Y. Tamaki, Y. Iwanaga, S. Niizuma, T. Kawashima, T. Kato, and Y. Inuzuka Metastasis-Associated protein, S100-A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts J Mol Cell Cardiol 57 2013 72 81
31. Z.H. Li, N.G. Dulyaninova, R.P. House, S.C. Almo, and A.R. Bresnick S100-A4 regulates macrophage chemotaxis Mol Biol Cell 21 2010 2598 2610
32. P. Bjork, E. Kallberg, U. Wellmar, M. Riva, A. Olsson, and Z. He Common interactions between S100-A4 and S100A9 defined by a novel chemical probe PLoS One 8 2013 e63012
33. D. Schuppan, and M. Pinzani Anti-fibrotic therapy: lost in translation? J Hepatol 56 2012 S66 S74
34. A. Baranova, P. Lal, A. Birerdinc, and Z.M. Younossi Non-invasive markers for hepatic fibrosis BMC Gastroenterol 11 2011 91